| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 29.06. | XFRA NEW INSTRUMENTS AVAILABLE ON 29.06.2026 | 287 | Xetra Newsboard | The following instruments on XETRA do have their first trading 29.06.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 29.06.2026
Aktien
1 CNE100006HX9 Jiangxi Rimag Group... ► Artikel lesen | |
| 23.06. | RIMAG GROUP (02522): VOLUNTARY ANNOUNCEMENT PURCHASE OF SHARES ON THE MARKET FOR THE SHARE AWARD SCHEME | 2 | HKEx | ||
| 02.06. | RIMAG GROUP (02522): CONNECTED TRANSACTION PROVISION OF FINANCIAL ASSISTANCE | - | HKEx | ||
| 27.04. | RIMAG GROUP (02522): DISCLOSEABLE TRANSACTION IN RELATION TO THE ACQUISITION OF 100% EQUITY INTERESTS IN THE TARGET COMPANIES INVOLVING THE ISSUE OF CONSIDERATION ... | 1 | HKEx | ||
| 23.04. | RIMAG GROUP (02522): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 4 | HKEx | ||
| 23.04. | RIMAG GROUP (02522): POLL RESULTS OF THE 2025 ANNUAL GENERAL MEETING HELD ON APRIL 23, 2026; AND CHANGE OF DIRECTORS AND MEMBERS OF THE BOARD COMMITTEES | - | HKEx | ||
| 31.03. | RIMAG GROUP (02522): 2025 ANNUAL REPORT | 2 | HKEx | ||
| JIANGXI RIMAG GROUP Aktie jetzt für 0€ handeln | |||||
| 31.03. | RIMAG GROUP (02522): 2025 ANNUAL RESULTS ANNOUNCEMENT | - | HKEx | ||
| 31.03. | RIMAG GROUP (02522): 2025 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT | - | HKEx | ||
| 31.03. | RIMAG GROUP (02522): FORM OF PROXY FOR THE 2025 ANNUAL GENERAL MEETING TO BE HELD ON APRIL 23, 2026 | - | HKEx | ||
| 31.03. | RIMAG GROUP (02522): NOTICE OF 2025 ANNUAL GENERAL MEETING | 1 | HKEx | ||
| 31.03. | RIMAG GROUP (02522): (1) 2025 ANNUAL REPORT; (2) WORK REPORT OF THE BOARD OF DIRECTORS FOR THE YEAR 2025; (3) WORK REPORT OF THE INDEPENDENT NON-EXECUTIVE ... | 1 | HKEx | ||
| 31.03. | RIMAG GROUP (02522): ELECTION OF NON-EXECUTIVE DIRECTOR | - | HKEx | ||
| 19.03. | RIMAG GROUP (02522): DATE OF BOARD MEETING | - | HKEx | ||
| 03.03. | RIMAG GROUP (02522): RESIGNATION OF NON-EXECUTIVE DIRECTOR | 4 | HKEx | ||
| 12.02. | RIMAG GROUP (02522): CONNECTED TRANSACTION PROVISION OF FINANCIAL ASSISTANCE | 2 | HKEx |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| LIFESTANCE HEALTH GROUP | 11,890 | -0,08 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 61,43 | -0,03 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| BILLIONTOONE | 98,60 | -0,05 % | BillionToOne sinks as outlook unchanged despite surging revenue | ||
| SIEMENS HEALTHINEERS | 39,000 | -0,43 % | BERNSTEIN RESEARCH stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat das Kursziel für Siemens Healthineers nach Zahlen zum dritten Geschäftsquartal von 45,70 auf 44,50 Euro gesenkt, aber die Einstufung... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 13,790 | +0,07 % | Can ALHC's Raised 2026 Outlook Offset Heavier Second-Half Spending? | ||
| PROCEPT BIOROBOTICS | 21,710 | 0,00 % | Jefferies senkt Kursziel für Procept BioRobotics nach verfehlten Eingriffszahlen | ||
| GENEDX | 77,85 | -0,04 % | Cathie Wood's ARK sells Palantir stock, buys GeneDx Holdings | ||
| PROGYNY | 27,850 | 0,00 % | Progyny, Inc. Announces Second Quarter 2026 Results | Reports Record Quarterly Revenue, Gross Profit and Adjusted EBITDARobust Selling Season Activity Continues to Reflect Strong Demand for Women's Health, Family Building SolutionsValue Returned to Shareholders... ► Artikel lesen | |
| ADAPTHEALTH | 5,210 | -0,19 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 22,375 | +0,02 % | Privia Health Group, Inc.: Privia Health Reports Strong Second Quarter and Year-to-Date 2026 Results | 2Q'26 Net Income of $9.0M, +236.7% from 2Q'252Q'26 Adjusted EBITDA of $37.4M, +29.1% from 2Q'25Full-Year 2026 Guidance Raised for All Key Financial Metrics ARLINGTON, Va., Aug. 06, 2026 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 29,640 | -1,20 % | Ihre wichtigsten Termine: Alle Analysten-Augen auf: Rheinmetall, Deutsche Telekom, Siemens, Airbnb & Lyft | © Foto: Julian Stratenschulte/dpa Gut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Untermehmenstermine... ► Artikel lesen | |
| BETA BIONICS | 16,365 | -0,21 % | Beta Bionics, Inc.: Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance | IRVINE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| FRESENIUS | 46,890 | -0,04 % | EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius hebt aufgrund der starken operativen Geschäftsentwicklung die Ergebnisprognose für das Geschäftsjahr 2026 an | EQS-Ad-hoc: Fresenius SE & Co. KGaA / Schlagwort(e): Prognose / Gesamtjahr
Fresenius SE & Co. KGaA: Fresenius hebt aufgrund der starken operativen Geschäftsentwicklung die Ergebnisprognose... ► Artikel lesen | |
| SANARA MEDTECH | 34,210 | 0,00 % | MiMedx Group, Inc.: MIMEDX to Acquire Sanara MedTech | Transformational Combination Creates a Leading Regenerative Medicine Company Across Numerous Surgical Subspecialties Accelerates MIMEDX's Strategic Priority to Expand Surgical Footprint, Nearly Doubling... ► Artikel lesen | |
| HEARTFLOW | 29,370 | +0,07 % | Heartflow, Inc.: Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the... ► Artikel lesen |